64 related articles for article (PubMed ID: 8616514)
1. Guanidine derivative U-37883A, inhibits mitochondrial K+ uniport.
Szewczyk A; Wójcik G; Jabłonowska A; Nałecz
Pol J Pharmacol; 1995; 47(4):339-44. PubMed ID: 8616514
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological Profile of U-37883A, a Channel Blocker of Smooth Muscle-Type ATP-Sensitive K Channels.
Teramoto N
Cardiovasc Drug Rev; 2006; 24(1):25-32. PubMed ID: 16939631
[TBL] [Abstract][Full Text] [Related]
3. Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells.
Guillemare E; Honore E; De Weille J; Fosset M; Lazdunski M; Meisheri K
Mol Pharmacol; 1994 Jul; 46(1):139-45. PubMed ID: 8058048
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the diuretics torasemide and U-37883A with the K(ATP) channel in rat isolated aorta.
Löffler-Walz C; Quast U
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):230-7. PubMed ID: 9750009
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of the K-ATP channel blocker U-37883A and structurally related morpholinoguanidines.
Humphrey SJ; Smith MP; Cimini MG; Buchanan LV; Gibson JK; Khan SA; Meisheri KD
Methods Find Exp Clin Pharmacol; 1996 May; 18(4):247-60. PubMed ID: 8803957
[TBL] [Abstract][Full Text] [Related]
6. 4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexylhydrochloride (U-37883A): pharmacological characterization of a novel antagonist of vascular ATP-sensitive K+ channel openers.
Meisheri KD; Humphrey SJ; Khan SA; Cipkus-Dubray LA; Smith MP; Jones AW
J Pharmacol Exp Ther; 1993 Aug; 266(2):655-65. PubMed ID: 8355199
[TBL] [Abstract][Full Text] [Related]
7. Diuretic activity of N'-disubstituted morpholinoguanidine analogs of U-37883A in rats and dogs.
Humphrey SJ; Ludens JH; Perricone SC; Skaletzky LL; Graham BE; Zins GR
Methods Find Exp Clin Pharmacol; 1995 May; 17(4):255-66. PubMed ID: 7475512
[TBL] [Abstract][Full Text] [Related]
8. Multiple actions of U-37883A, an ATP-sensitive K+ channel blocker, on membrane currents in pig urethra.
Tomoda T; Yunoki T; Naito S; Ito Y; Teramoto N
Eur J Pharmacol; 2005 Nov; 524(1-3):1-10. PubMed ID: 16242124
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of vascular K(ATP) channels by U-37883A: a comparison with cardiac and skeletal muscle.
Wellman GC; Barrett-Jolley R; Köppel H; Everitt D; Quayle JM
Br J Pharmacol; 1999 Oct; 128(4):909-16. PubMed ID: 10556925
[TBL] [Abstract][Full Text] [Related]
10. Effects of a K+ channel blocker on glomerular filtration rate and electrolyte excretion in conscious rats.
Ludens JH; Clark MA; Lawson JA
J Pharmacol Exp Ther; 1995 Jun; 273(3):1375-81. PubMed ID: 7791110
[TBL] [Abstract][Full Text] [Related]
11. Effects of K-ATP blocking guanidine diuretics during experimental kaliuresis in rats and dogs.
Humphrey SJ
Methods Find Exp Clin Pharmacol; 1995 Oct; 17(8):519-28. PubMed ID: 8749224
[TBL] [Abstract][Full Text] [Related]
12. Effects of U-37883A on intracellular Ca2+ -activated large-conductance K+ channels in pig proximal urethral myocytes.
Teramoto N; Aishima M; Zhu HL; Tomoda T; Yunoki T; Takahashi-Yanaga F; Brading AF; Ito Y
Eur J Pharmacol; 2004 Dec; 506(1):1-7. PubMed ID: 15588618
[TBL] [Abstract][Full Text] [Related]
13. Receptor binding characterization in kidney membrane of [3H]U-37883, a novel ATP-sensitive K+ channel blocker with diuretic/natriuretic properties.
Meisheri K; Fosset M; Humphrey S; Lazdunski M
Mol Pharmacol; 1995 Jan; 47(1):155-63. PubMed ID: 7838124
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of glyburide and U-37883A, two structurally different vascular ATP-sensitive potassium channel antagonists.
Ohrnberger CE; Khan SA; Meisheri KD
J Pharmacol Exp Ther; 1993 Oct; 267(1):25-30. PubMed ID: 8229751
[TBL] [Abstract][Full Text] [Related]
15. An antagonist of ATP-regulated potassium channels, the guanidine derivative U-37883A, stimulates the synthesis of phosphatidylserine in rat liver endoplasmic reticulum membranes.
Makowski P; Szewczyk A; Jasińska R; Pikuła S
FEBS Lett; 1997 Jun; 409(2):292-6. PubMed ID: 9202164
[TBL] [Abstract][Full Text] [Related]
16. U-37883A potently inhibits dopamine-modulated K+ channels on rat striatal neurons.
Lin YJ; Chen X; Freedman JE
Eur J Pharmacol; 1998 Jul; 352(2-3):335-41. PubMed ID: 9716371
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and diuretic activity of alkyl- and arylguanidine analogs of N,N'-dicyclohexyl-4-morpholinecarboxamidine in rats and dogs.
Perricone SC; Humphrey SJ; Skaletzky LL; Graham BE; Zandt RA; Zins GR
J Med Chem; 1994 Oct; 37(22):3693-700. PubMed ID: 7966129
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of the subtype-selective inhibition of cloned KATP channels by PNU-37883A.
Kovalev H; Quayle JM; Kamishima T; Lodwick D
Br J Pharmacol; 2004 Mar; 141(5):867-73. PubMed ID: 14757705
[TBL] [Abstract][Full Text] [Related]
19. Renal and vascular effects of chemically distinct ATP-sensitive K+ channel blockers in rats.
Ludens JH; Clark MA; Smith MP; Humphrey SJ
J Cardiovasc Pharmacol; 1995 Mar; 25(3):404-9. PubMed ID: 7769805
[TBL] [Abstract][Full Text] [Related]
20. K-ATP-blocking diuretic PNU-37883A reduces plasma renin activity in dogs.
Humphrey SJ; Ludens JH
J Cardiovasc Pharmacol; 1998 Jun; 31(6):894-903. PubMed ID: 9641474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
